JP2021520210A5 - - Google Patents
Info
- Publication number
- JP2021520210A5 JP2021520210A5 JP2020554298A JP2020554298A JP2021520210A5 JP 2021520210 A5 JP2021520210 A5 JP 2021520210A5 JP 2020554298 A JP2020554298 A JP 2020554298A JP 2020554298 A JP2020554298 A JP 2020554298A JP 2021520210 A5 JP2021520210 A5 JP 2021520210A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- cmklr1
- compound
- amino acid
- nucleic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024081730A JP2024105648A (ja) | 2018-04-03 | 2024-05-20 | 抗ケモカイン様受容体１抗体及びその治療応用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18305395.8 | 2018-04-03 | ||
| EP18305395 | 2018-04-03 | ||
| PCT/EP2019/058358 WO2019193029A1 (en) | 2018-04-03 | 2019-04-03 | Anti-chemokin like receptor 1 antibodies and their therapeutic applications |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024081730A Division JP2024105648A (ja) | 2018-04-03 | 2024-05-20 | 抗ケモカイン様受容体１抗体及びその治療応用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021520210A JP2021520210A (ja) | 2021-08-19 |
| JP2021520210A5 true JP2021520210A5 (https=) | 2022-05-10 |
Family
ID=62046804
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020554298A Pending JP2021520210A (ja) | 2018-04-03 | 2019-04-03 | 抗ケモカイン様受容体１抗体及びその治療応用 |
| JP2024081730A Revoked JP2024105648A (ja) | 2018-04-03 | 2024-05-20 | 抗ケモカイン様受容体１抗体及びその治療応用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024081730A Revoked JP2024105648A (ja) | 2018-04-03 | 2024-05-20 | 抗ケモカイン様受容体１抗体及びその治療応用 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20210147558A1 (https=) |
| EP (2) | EP3774899A1 (https=) |
| JP (2) | JP2021520210A (https=) |
| KR (2) | KR102802041B1 (https=) |
| CN (2) | CN120484119A (https=) |
| AU (2) | AU2019247068A1 (https=) |
| BR (1) | BR112020020118A2 (https=) |
| CA (1) | CA3102607A1 (https=) |
| IL (2) | IL321209A (https=) |
| MA (1) | MA52174A (https=) |
| WO (1) | WO2019193029A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11730705B2 (en) * | 2019-05-02 | 2023-08-22 | The Board Of Trustees Of The Leland Stanford Junior University | Small molecule CMKLR1 antagonists in inflammatory disease |
| PH12022550844A1 (en) * | 2019-10-09 | 2023-06-14 | Ose Immunotherapeutics | Anti-chemokin like receptor 1 humanized antibodies and their therapeutic applications |
| EP3804754A1 (en) * | 2019-10-09 | 2021-04-14 | OSE Immunotherapeutics | Cmklr1 agonists having a resolvin e1-like capability and their therapeutic applications |
| CN120643848A (zh) | 2021-01-15 | 2025-09-16 | 瑞尔科技有限公司 | 便携式紧急逃生装置 |
| WO2023076329A1 (en) * | 2021-10-26 | 2023-05-04 | Thetis Pharmaceuticals Llc | Compositions and methods for cancer therapy |
| WO2024028509A2 (en) | 2022-08-05 | 2024-02-08 | Ose Immunotherapeutics | Treatment of an inflammation-associated disease in a patient expressing high chemerin level |
| WO2024028508A2 (en) | 2022-08-05 | 2024-02-08 | Ose Immunotherapeutics | Anti-chemokin like receptor 1 antibody or antigen-binding fragment thereof for use in the treatment of conditions associated with netosis |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19742706B4 (de) | 1997-09-26 | 2013-07-25 | Pieris Proteolab Ag | Lipocalinmuteine |
| US7419658B2 (en) * | 2001-07-09 | 2008-09-02 | Euroscreen S.A. | Isolated ligand of ChemerinR |
| US20070286863A1 (en) * | 2006-05-17 | 2007-12-13 | Christopher Sinal | CMKLR regulation of adipogenesis and adipocyte metabolic function |
| EP1930342B1 (en) | 2006-12-04 | 2012-01-25 | Institut Pasteur | OB-fold used as scaffold for engineering new specific binders |
| US8038992B2 (en) * | 2008-05-10 | 2011-10-18 | The Board Of Trustees Of The Leland Stanford Junior University | Target for regulating multiple sclerosis |
| WO2013109543A1 (en) * | 2012-01-20 | 2013-07-25 | The Board Of Trustees Of The Leland Stanford Junior University | Small molecule cmklr1 antagonists in demyelinating disease |
| JP5883515B2 (ja) * | 2012-02-06 | 2016-03-15 | エーエスエムエル ネザーランズ ビー．ブイ． | 対象物を保持するための支持構造を備えるリソグラフィ装置及びそれに用いられる支持構造 |
| CN102816209A (zh) * | 2012-07-09 | 2012-12-12 | 深圳先进技术研究院 | 一种趋化素衍生肽及其表达基因和应用 |
-
2019
- 2019-04-03 IL IL321209A patent/IL321209A/en unknown
- 2019-04-03 WO PCT/EP2019/058358 patent/WO2019193029A1/en not_active Ceased
- 2019-04-03 AU AU2019247068A patent/AU2019247068A1/en not_active Abandoned
- 2019-04-03 JP JP2020554298A patent/JP2021520210A/ja active Pending
- 2019-04-03 MA MA052174A patent/MA52174A/fr unknown
- 2019-04-03 CA CA3102607A patent/CA3102607A1/en active Pending
- 2019-04-03 EP EP19715092.3A patent/EP3774899A1/en active Pending
- 2019-04-03 US US17/045,130 patent/US20210147558A1/en not_active Abandoned
- 2019-04-03 CN CN202510632905.9A patent/CN120484119A/zh active Pending
- 2019-04-03 KR KR1020207031788A patent/KR102802041B1/ko active Active
- 2019-04-03 BR BR112020020118-9A patent/BR112020020118A2/pt unknown
- 2019-04-03 KR KR1020257013411A patent/KR20250065423A/ko active Pending
- 2019-04-03 EP EP25194341.1A patent/EP4656247A3/en active Pending
- 2019-04-03 CN CN201980037001.4A patent/CN112218894A/zh active Pending
-
2020
- 2020-09-30 IL IL277701A patent/IL277701A/en unknown
-
2024
- 2024-05-08 US US18/658,406 patent/US20240400698A1/en active Pending
- 2024-05-20 JP JP2024081730A patent/JP2024105648A/ja not_active Revoked
-
2026
- 2026-01-19 AU AU2026200353A patent/AU2026200353A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021520210A5 (https=) | ||
| JP7328658B2 (ja) | 抗ｐｄ－ｌ１／抗４－１ｂｂ二重特異性抗体およびその使用 | |
| JP6740308B2 (ja) | 骨髄細胞で発現されるトリガー受容体１（ｔｒｅｍ−１）に結合し、それを遮断する抗体 | |
| TWI701259B (zh) | ４﹘１ｂｂ抗體及其製備方法和應用 | |
| RU2509777C2 (ru) | Анти-mif антитела | |
| TW201833141A (zh) | 抗b7-h3抗體、其抗原結合片段及其醫藥用途 | |
| KR20170138494A (ko) | 항-ｔｙｒ０３ 항체 및 이의 용도 | |
| CN104203977A (zh) | 结合肽聚糖识别蛋白1的抗体 | |
| JP6851322B2 (ja) | 神経疾患を治療する方法 | |
| JP2025523933A (ja) | 抗アドレノメデュリン非中和抗体、その製造方法及び使用 | |
| KR20250143753A (ko) | 다가 및 다중특이적 시토카인 길항제 | |
| TW202144433A (zh) | 抗體或其抗原結合片段、其製備方法及醫藥用途 | |
| JP2024520338A (ja) | 抗ｉｌ－１受容体アクセサリータンパク質抗体 | |
| CA3151450A1 (en) | Protein binders to irhom2 epitopes | |
| AU2022413905A1 (en) | Anti-pilra antibodies, uses thereof, and related methods and reagents | |
| CA3208070A1 (en) | Humanized antibodies against irhom2 | |
| CN115109157A (zh) | 抗体或其抗原结合片段，其制备方法及医药用途 | |
| HK40115111A (zh) | 抗pilra抗体、其用途以及相关方法和试剂 | |
| WO2024078558A1 (zh) | 抗cd100抗体及其用途 | |
| WO2025152915A1 (zh) | 抗肾上腺髓质素抗体在预防或治疗脑卒中的应用 | |
| WO2026017189A2 (zh) | 抗il-31抗体、其药物组合物及用途 | |
| CN119301153A (zh) | 结合il-17a和il-17f的抗体分子及其应用 | |
| HK40119194A (zh) | IL-1β结合蛋白的材料和方法 | |
| CA2856141C (en) | Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or an anti-adm non-ig scaffold for use in therapy | |
| JP2011510617A (ja) | 精製タグ又は不活性可変ドメインを具えるタンパク性結合分子 |